1. Home
  2. ASMB vs MDV Comparison

ASMB vs MDV Comparison

Compare ASMB & MDV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ASMB
  • MDV
  • Stock Information
  • Founded
  • ASMB 2005
  • MDV 2015
  • Country
  • ASMB United States
  • MDV United States
  • Employees
  • ASMB N/A
  • MDV N/A
  • Industry
  • ASMB Biotechnology: Pharmaceutical Preparations
  • MDV Transportation Services
  • Sector
  • ASMB Health Care
  • MDV Consumer Discretionary
  • Exchange
  • ASMB Nasdaq
  • MDV Nasdaq
  • Market Cap
  • ASMB 141.8M
  • MDV 147.6M
  • IPO Year
  • ASMB 2010
  • MDV 2022
  • Fundamental
  • Price
  • ASMB $18.51
  • MDV $14.51
  • Analyst Decision
  • ASMB Strong Buy
  • MDV
  • Analyst Count
  • ASMB 3
  • MDV 0
  • Target Price
  • ASMB $33.00
  • MDV N/A
  • AVG Volume (30 Days)
  • ASMB 43.3K
  • MDV 111.0K
  • Earning Date
  • ASMB 08-07-2025
  • MDV 08-05-2025
  • Dividend Yield
  • ASMB N/A
  • MDV 8.08%
  • EPS Growth
  • ASMB N/A
  • MDV N/A
  • EPS
  • ASMB N/A
  • MDV N/A
  • Revenue
  • ASMB $32,154,000.00
  • MDV $46,738,000.00
  • Revenue This Year
  • ASMB $0.04
  • MDV $2.21
  • Revenue Next Year
  • ASMB N/A
  • MDV $4.45
  • P/E Ratio
  • ASMB N/A
  • MDV N/A
  • Revenue Growth
  • ASMB 148.33
  • MDV N/A
  • 52 Week Low
  • ASMB $7.75
  • MDV $13.62
  • 52 Week High
  • ASMB $19.93
  • MDV $18.11
  • Technical
  • Relative Strength Index (RSI)
  • ASMB 63.34
  • MDV 49.82
  • Support Level
  • ASMB $18.13
  • MDV $14.50
  • Resistance Level
  • ASMB $19.11
  • MDV $14.91
  • Average True Range (ATR)
  • ASMB 0.81
  • MDV 0.28
  • MACD
  • ASMB -0.06
  • MDV 0.04
  • Stochastic Oscillator
  • ASMB 77.83
  • MDV 51.87

About ASMB Assembly Biosciences Inc.

Assembly Biosciences Inc is a clinical-stage biotechnology company. It is advancing two platform programs, a novel class of oral therapeutics for the treatment of hepatitis B virus (HBV) infection and novel class of oral synthetic live biotherapeutics, which are designed to restore health to a dysbiotic microbiome. The company's HBV-cure program is aimed at increasing the current low cure rate for patients with HBV and is pursuing multiple drug candidates that inhibit multiple steps of the HBV lifecycle. Assembly has discovered several novel core protein Allosteric Modulators, which are small molecules that directly target and allosterically modulate the HBV core protein. The majority of the revenue is generated from the HBV cure program.

About MDV Modiv Industrial Inc. Class C

Modiv Industrial Inc is a pioneer in the direct-to-consumer commercial real estate product industry. It provides individual investors access to real estate and real estate-related investments designed to provide both income and long-term growth. The Company has invested in single-tenant income-producing properties. Its current business consists of owning, managing, operating, leasing, acquiring, investing in and disposing of commercial real estate assets utilized for industrial manufacturing, as well as a few non-core assets. All of the company's consolidated revenues are derived from company's consolidated real estate properties.

Share on Social Networks: